Shraddha R. Desai, Ph.D.
Affiliations: | 2011 | Chemistry | University of South Florida, Tampa, FL, United States |
Area:
Biochemistry, Cell BiologyGoogle:
"Shraddha Desai"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Mildred Acevedo-Duncan | grad student | 2011 | University of South Florida | |
| (Role of Protein kinase C-iota in Glioblastoma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bowie M, Pilie P, Wulfkuhle J, et al. (2015) Fluoxetine induces cytotoxic endoplasmic reticulum stress and autophagy in triple negative breast cancer. World Journal of Clinical Oncology. 6: 299-311 |
| Desai SR, Dietze EC, Skaar D, et al. (2015) Abstract PR11: Loss of imprinting: Tying prenatal diet to the aggressive biology of triple-negative breast cancer Cancer Epidemiology, Biomarkers & Prevention. 24 |
| McCray AN, Desai S, Acevedo-Duncan M. (2014) The interruption of PKC-ι signaling and TRAIL combination therapy against glioblastoma cells. Neurochemical Research. 39: 1691-701 |
| Desai S, Skaar D, Dietze E, et al. (2014) Abstract C65: Loss of imprinting of KCNK9 in African American women with triple-negative breast cancer Cancer Epidemiology, Biomarkers & Prevention. 23 |
| Seewaldt V, Skaar D, Dietze E, et al. (2014) Abstract 28: Chemoprevention strategies to target abnormal imprinting in high-risk African American women who do or do not carry a BRCA1 mutation Cancer Research. 74: 28-28 |
| McCray AN, Desai S, Acevedo-Duncan M. (2013) Abstract 2952: The PKC-iota inhibitor ICA-1 combined with TRAIL for glioblastoma therapy. Cancer Research. 73: 2952-2952 |
| Desai SR, Pillai PP, Patel RS, et al. (2012) Regulation of Cdk7 activity through a phosphatidylinositol (3)-kinase/PKC-ι-mediated signaling cascade in glioblastoma. Carcinogenesis. 33: 10-9 |
| Desai S, Patel R, McCray AN, et al. (2012) Abstract 3760: A novel PKC-iota inhibitor, ICA-1 abrogates cell proliferation in breast cancer Cancer Research. 72: 3760-3760 |
| Desai S, Pillai P, Win-Piazza H, et al. (2011) PKC-3 promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway Biochimica Et Biophysica Acta - Molecular Cell Research. 1813: 1190-1197 |
| Pillai P, Desai S, Patel R, et al. (2011) A novel PKC-ι inhibitor abrogates cell proliferation and induces apoptosis in neuroblastoma. The International Journal of Biochemistry & Cell Biology. 43: 784-94 |